Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
16 09 2021
Historique:
received: 03 03 2021
pubmed: 26 5 2021
medline: 17 2 2022
entrez: 25 5 2021
Statut: ppublish

Résumé

Starting from our previously reported hit, a series of 1,5-diaryl-1,2,3-triazole-4-carbohydrazones were synthesized and evaluated as inhibitors of the YAP/TAZ-TEAD complex. Their binding to hTEAD2 was confirmed by nanodifferential scanning fluorimetry, and some of the compounds were also found to moderately disrupt the YAP-TEAD interaction, as assessed by a fluorescence polarization assay. A TEAD luciferase gene reporter assay performed in HEK293T cells and RTqPCR measurements in MDA-MB231 cells showed that these compounds inhibit YAP/TAZ-TEAD activity to cells in the micromolar range. In spite of the cytotoxic effects displayed by some of the compounds of this series, they are still good starting points and can be suitably modified into an effective and viable YAP-TEAD disruptor in the future.

Identifiants

pubmed: 34032019
doi: 10.1002/cmdc.202100153
doi:

Substances chimiques

Antineoplastic Agents 0
Hydrazones 0
TEA Domain Transcription Factors 0
TEAD2 protein, human 0
Transcriptional Coactivator with PDZ-Binding Motif Proteins 0
Triazoles 0
YAP-Signaling Proteins 0
YAP1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2823-2844

Subventions

Organisme : le Ministère de l'Education et de la Recherche
Organisme : SIRIC OncoLille and le Cancéropôle Nord-Ouest
ID : 2016/09
Organisme : Région Nord Pas-de-Calais
Organisme : Ministère de la Jeunesse, de l'Education Nationale et de la Recherche
Organisme : Fonds Européens de Développement Régional

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

Z. Meng, T. Moroishi, K. L. Guan, Genes Dev. 2016, 30, 1-17.
Y. Wang, X. Xu, D. Maglic, M. T. Dill, K. Mojumdar, P. K. Ng, K. J. Jeong, Y. H. Tsang, D. Moreno, V. H. Bhavana, X. Peng, Z. Ge, H. Chen, J. Li, Z. Chen, H. Zhang, L. Han, D. Du, C. J. Creighton, G. B. Mills, F. Camargo, H. Liang, Cell Rep. 2018, 25, 1304-1317.
U. Ehmer, J. Sage, Mol. Cancer Res. 2016, 14, 127-140.
H. Liu, S. Du, T. Lei, H. Wang, X. He, R. Tong, Y. Wang, Oncol. Rep. 2018, 40, 16-28.
X. Y. Ji, G. Zhong, B. Zhao, Yichuan 2017, 39, 546-567.
L. Cairns, T. Tran, J. M. Kavran, ACS Chem. Biol. 2017, 12, 601-610.
A. L. Zygulska, K. Krzemieniecki, P. Pierzchalski, J. Physiol. Pharmacol. 2017, 68, 311-335.
L. Wu, X. Yang, Cancers (Basel).). 2018 Nov 5;10(11). pii: E422. doi: 10.3390/cancers10110422.
J. S. A. Warren, Y. Xiao, J. M. Lamar, J. M. Cancers (Basel). 2018 Apr 10;10(4). pii: E115. doi: 10.3390/cancers10040115.
Y. Sekido, Cancers (Basel). 2018 Mar 22;10(4). pii: E90. doi: 10.3390/cancers10040090.
J. H. Park, J. E. Shin, H. W. Park, Mol. Cells 2018, 41, 83-92.
F. Zanconato, M. Cordenonsi, S. Piccolo, Cancer Cell. 2016, 29, 783-803.
A. V. Pobbati, W. Hong, Theranostics 2020, 10, 3622-3635.
R. Song, D. Gu, L. Zhang, X. Zhang, B. Yu, B. Liu, J. Xie, Mol. Carcinog. 2018, 57, 1608-1615.
T. S. Gujral, M. W. Kirschner, Proc. Natl. Acad. Sci. USA 2017, 114, E3729-E3738.
C. Yang, J. Tan, J. Zhu, S. Wang, G. Wei, Oncotarget. 2017, 8, 37154-37163.
C. Wei, Y. Wang, X. Li, Oncotarget 2018, 11, 2185-2193.
H. J. Janse van Rensburg, X. Yang, Cell. Signalling 2016, 28, 1761-1772.
J. S. Bae, S. M. Kim, H. Lee, Oncotarget. 2017, 8, 16084-16098.
G. M. Elisi, M. Santucci, D . D'Arca, A. Lauriola, G. Marverti, L. Losi, L. Scalvini, M. L. Bolognesi, M. Mor, M. P. Costi, Cancers (Basel). 2018 Sep 14;10(9). pii: E329. doi: 10.3390/cancers10090329.
M. Barth, S. Contal, C. Montalbetti, L. Spitzer, PCT Int. Appl., WO 2017064277 A1 20170420, 2017.
S. Song, M. Xie, A. W. Scott, J. Jin, L. Ma, X. Dong, H. D. Skinner, R. L. Johnson, S. Ding, J. A. Ajani, Mol. Cancer Ther. 2018, 17, 443-454.
J. K. Holden, C. N. Cunningham, Cancers (Basel). 2018 Mar 20;10(3). pii: E81. doi: 10.3390/cancers10030081.
F. Gibault, M. Sturbaut, F. Bailly, P. Melnyk, P. Cotelle, J. Med. Chem. 2018, 61, 5057-5072.
K. C. Lin, H. W. Park, K. L. Guan, Trends Biochem. Sci. 2017, 42, 862-872.
H. D. Huh, D. H. Kim, H. S. Jeong, H. W. Park, Cells. 2019, 8. pii: E600. doi: 10.3390/cells8060600.
A. V. Pobbati, B. P. Rubin, Molecules 2020, 25, 6001.
A. V. Pobbati, X. Han, A. W. Hung, S. Weiguang, N. Huda, G. Y. Chen, C. Kang, C. S. B. Chia, X. Luo, W. Hong, A. Poulsen, Structure. 2015, 23, 2076-2086.
S. A. Smith, R. B. Sessions, D. K. Shoemark, C. Williams, R. Ebrahimighaei, M. C. McNeill, M. P. Crump, T. R. McKay, G. Harris, A. C. Newby, M. Bond, J. Med. Chem. 2019, 62, 1291-1305.
Z. Li, B. Zhao, P. Wang, F. Chen, Z. Dong, H. Yang, K. L. Guan, Y. Xu, Genes Dev. 2010, 24, 235-240.
F. Gibault, M. Coevoet, M. Sturbaut, A. Farce, N. Renault, F. Allemand, J. F. Guichou, A. S. Drucbert, C. Foulon, R. Magnez, X. Thuru, M. Corvaisier, G. Huet, P. Chavatte, P. Melnyk, F. Bailly, P. Cotelle, Cancers (Basel). 2018 May 8;10(5). pii: E140. doi: 10.3390/cancers10050140.
G. Biagi, V. Calderone, I. Giorgi, O. Livi, E. Martinotti, A. Martelli, A. Nardi, Il Farmaco 2004, 59, 397-404.
G. Biagi, I. Giorgi, O. Livi, V. Scartoni, P. L. Barli, J. Heterocycl. Chem. 1995, 32, 1709-1714.
S. Kashanian, M. M. Khodaei, P. Pakravan, H. Adibi, Mol. Biol. Rep. 2012, 39, 3853-3861.
H. Adibi, M. M. Khodaei, P. Pakravan, R. Abiri, Pharm. Chem. J. 2010, 44, 219-227.
B. O. Buckman, J. B. Nicholas, K. Emayan, S. D. Seiwert, US 2014/0200215 A1, 2014.
G. Zhang, H. Ni, W. Chen, J. Shao, H. Liu, B. Chen, Y. Yu, Org. Lett. 2013, 15, 5967-5969.
J. K. Augustine, A. Bombrun, S. Venkatachaliah, A. Jothi, Org. Biomol. Chem. 2013, 11, 8065-8072.
V. K. Gore, V. V. Ma, R. Tamir, N. R. Gavva, J. J. S. Treanor, M. H. Norman, Bioorg. Med. Chem. Lett. 2007, 17, 5825-5830.
Y. Oku, N. Nishiya, T. Shito, R. Yamamoto, C. Oyama, Y. Uehara, FEBS Open Bio. 2015, 5, 542-549.
C. Taccioli, G. Sorrentino, A. Zannini, J. Caroli, D. Beneventano, L. Anderlucci, M. Lolli, S. Bicciato, G. Del Sal, Oncotarget. 2015, 6, 38854-38865.
Z. Zhang, Z. Lin, Z. Zhou, H. C. Shen, S. F. Yan, A. V. Mayweg, Z. Xu, N. Qin, J. C. Wong, Z. Zhang, Y. Rong, D. C. Fry, T. Hu, ACS Med. Chem. Lett. 2014, 5, 993-998.
Z. Zhang, Z. Lin, Z. Zhou, H. C. Shen, S. F. Yan, A. V. Mayweg, Z. Xu, N. Qin, J. C. Wong, Z. Zhang, Y. Rong, D. C. Fry, T. Hu, ACS Med. Chem. Lett. 2014, 5, 993-998.
C. L. Noland, S. Gierke, P. D. Schnier, J. Murray, W. N. Sandoval, M. Sagolla, A. Dey, R. N. Hannoush, W. J. Fairbrother, C. N. Cunningham, Structure 2016, 24, 179-186.
P. Chan, X. Han, B. Zheng, M. DeRan, J. Yu, G. K. Jarugumilli, H. Deng, D. Pan, X. Luo, X. Wu, Nat. Chem. Biol. 2016, 12, 282-289.
J. K. Holden, J. J. Crawford, C. L. Noland, S. Schmidt, J. R. Zbieg, J. A. Lacap, R. Zang, G. M. Miller, Y. Zhang, P. Beroza, R. Reja, W. Lee, J. Y. K. Tom, R. Fong, M. Steffek, S. Clausen, T. J. Hagenbeek, T. Hu, Z. Zhou, H. C. Shen, C. N. Cunningham, Cell Rep. 2020, 31, 107809.
H. Karatas, M. Akbarzadeh, H. Adihou, G. Hahne, A. V. Pobbati, E. Yihui Ng, S. M. Guéret, S. Sievers, A. Pahl, M. Metz, S. Zinken, L. Dötsch, C. Nowak, S. Thavam, A. Friese, C. Kang, W. Hong, H. Waldmann, J. Med. Chem. 2020, 63, 11972-11989.
Y. Li, S. Liu, E. Yihui Ng, R. Li, A. Poulsen, J. Hill, A. V. Pobbati, A. W. Hung, W. Hong, T. H. Keller, C. Kang, Biochem. J. 2018, 475, 2043-2055.
Y. Xu, S. Wang, Q. Hu, S. Gao, X. Ma, W. Zhang, Y. Shen, F. Chen, L. Lai, J. Pei, Nucleic Acids Res. 2018, 46, W374-W379.
O. Trott, A. J. Olson„ J. Comput. Chem. 2010, 31, 455-461.

Auteurs

Floriane Gibault (F)

INSERM, UMR-S 1172, Lille Neuroscience & Cognition, University of Lille, 59000, Lille, France.

Manon Sturbaut (M)

INSERM, UMR-S 1172, Lille Neuroscience & Cognition, University of Lille, 59000, Lille, France.

Mathilde Coevoet (M)

INSERM, UMR-S 1172, Lille Neuroscience & Cognition, University of Lille, 59000, Lille, France.

Martine Pugnière (M)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Institut Régional du Cancer de Montpellier (ICM), University of Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France.

Ashley Burtscher (A)

Robert J. Tomsich Pathology and Laboratory Medicine Institute and Department of Cancer Biology, Cleveland Clinic, Lerner Research Institute and Taussig Cancer Center, Cleveland, OH 44195, USA.

Frédéric Allemand (F)

University of Montpellier CNRS UMR5048, INSERM U1054 Centre de Biologie Structurale, 29 rue de Navacelles, 34090, Montpellier, France.

Patricia Melnyk (P)

INSERM, UMR-S 1172, Lille Neuroscience & Cognition, University of Lille, 59000, Lille, France.

Wanjin Hong (W)

Institute of Molecular and Cell Biology, A(✶)STAR, 61 Biopolis Drive, Singapore 138673, Singapore.

Brian P Rubin (BP)

Robert J. Tomsich Pathology and Laboratory Medicine Institute and Department of Cancer Biology, Cleveland Clinic, Lerner Research Institute and Taussig Cancer Center, Cleveland, OH 44195, USA.

Ajaybabu V Pobbati (AV)

Robert J. Tomsich Pathology and Laboratory Medicine Institute and Department of Cancer Biology, Cleveland Clinic, Lerner Research Institute and Taussig Cancer Center, Cleveland, OH 44195, USA.

Jean-François Guichou (JF)

University of Montpellier CNRS UMR5048, INSERM U1054 Centre de Biologie Structurale, 29 rue de Navacelles, 34090, Montpellier, France.

Philippe Cotelle (P)

INSERM, UMR-S 1172, Lille Neuroscience & Cognition, University of Lille, 59000, Lille, France.
Ecole Centrale Lille, 59000, Lille, France.

Fabrice Bailly (F)

INSERM, UMR-S 1172, Lille Neuroscience & Cognition, University of Lille, 59000, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH